MENU CLOSE

News & Events

2025 Accelerator

  • $7M invested in early-stage therapies through the Myeloma Investment Fund®, including in vivo CAR T-cell treatments
  • Horizon Clinical Trials testing advanced therapies for relapsed and high-risk patients
  • And so much more…

Download the PDF